期刊文献+

葛根素注射液治疗冠心病不稳定型心绞痛的临床研究 被引量:5

Curative Effects of Puerarin Injection on Unstable Angina Pectoris
下载PDF
导出
摘要 目的:观察葛根素注射液治疗冠心病不稳定型心绞痛的临床疗效及对心肌供血的影响。方法:冠心病不稳定型心绞痛患者80例采用随机数字表法分为对照组(常规西药治疗)和治疗组,后者在常规西药治疗基础上加用葛根素注射液;观察临床疗效、静息心电图ST段变化和24h动态心电图心肌缺血总负荷(TIB)变化。结果:两组患者临床疗效显著,具有明显改善静息心电图ST段变化和TIB,且治疗组临床疗效和TIB优于对照组。结论:葛根素注射液治疗不稳定型心绞痛临床疗效显著,能明显改善心肌供血。 Objective: To explore the curative effects of Puerarin injection on unstable angina peetoris ( UAP ). Methods : Eighty UAP cases were randomly divided into control group ( routine western medicine ) and treatment group which took not only routine western medicine but also Puerarin injection. We studied its clinical effect," silent ECG and total insufficient burden ( TIB ) of 24-hour holter ECG. Results Not only the clinical action rises rapidly and effectively, but coronary artery insufficient is alleviated in each group. Conclusion Puerarin injection, a new fast-effective preparation for prevention and treatment of UAP, is worth being further researched for clinical using.
出处 《辽宁中医药大学学报》 CAS 2008年第5期3-5,共3页 Journal of Liaoning University of Traditional Chinese Medicine
基金 江苏省中医药管理局课题(2003-2004)
关键词 不稳定型心绞痛 葛根素注射液 临床疗效 心肌缺血总负荷 puerarin injection unstable angina pectoris clinical effect total insufficient burden
  • 相关文献

参考文献12

  • 1不稳定性心绞痛诊断和治疗建议[J].中华心血管病杂志,2000,28(6):409-412. 被引量:2695
  • 2陈可冀.心脑血管疾病研究[M].上海:上海科学技术出版社,1988..
  • 3[4]Abbate A,Biondi-Zoocai GG,Brugaletta S,et al.C-reactive protein and other inflammatory biomarkers as predictors of outcome follo wing acute coronary syndromes[J].Semin Vasc Med.2003 Nov,3(4):375-84.
  • 4[5]Biasucci LM,Liuzzo G,Grillo RL,et al.Elevated levels of c-reactive protein at discharge in patients with unstable angina predict recurrent instability[J].Circulation,1999,99:855-860.
  • 5[6]Biasucci LM,Viteli A,Liuzzo G,et al.Elevated levels of interleukin-6 in unstable angina[J].Circulation,1996,94:874-877.
  • 6刘金来,关良劲,谢旭晶,陈璘.急性冠状动脉综合征患者血浆基质金属蛋白酶及其抑制因子的变化[J].中国病理生理杂志,2004,20(10):1921-1922. 被引量:20
  • 7[8]Manginas A,Bei E,Chaidaroglou A,et al.Peripheral levels of matrix metalloproteinase-9,interleukin-6,and C-reactive protein are elevated in patients with acute coronary syndromes:correlations with serum troponin I[J].Clin Cardiol.2005 Apr,28(4):182-186.
  • 8[9]Kohler HP.Plasminogen-activator inhibitor type 1 and coronary artery disease[J].N Eng J Med,2000,342(24):1792.
  • 9王忠良,钱士明,张寒梅.稳心方联合心理干预治疗不稳定型心绞痛焦虑疗效研究[J].辽宁中医杂志,2006,33(4):422-423. 被引量:2
  • 10范礼理,曾贵云.葛根的药理研究Ⅱ-葛根黄铜对冠状循环心脏血流动力学和心肌代谢的作用[J].中华医学杂志,1975,55(10):724.

二级参考文献12

  • 1陈灏珠.实用内科学[M].北京:人民卫生出版社,2001.953.
  • 2Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I[J]. Circulation, 2003, 108(14):1664-1672.
  • 3Kaartinen M, van der Wal AC, van der Loos CM, et al. Mast cell infiltration in acute coronary syndromes: implications for plaque rupture[J]. J Am Coll Cardiol, 1998, 32(3): 606-612.
  • 4Schonbeck U, Mach F, Sukhova GK, et al. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T-lymphocytes: A role for CD40 signaling in plaque rupture [J]. Circ Res, 1997, 81(3): 448-454.
  • 5Haverkate F, Thompson SG, Pyke SD, et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina[J]. Lancet, 1997, 349(9050): 462-466.
  • 6Inokubo Y, Hanada H, Ishizaka H, et al. Plasma levels of matrix metalloproteinases-9 and tissue inhibitor metalloproteinase-1 are increased in patients with acute coronary syndrome[J]. Am Heart J, 2001, 141(2): 211-217.
  • 7WHO缺血性心脏病的命名及诊断标准[J].中华内科杂志,1981,20(6):254-254.
  • 8吕欣然,陈淑梅,孙塘.葛根对β-肾上腺素能受体阻滞作用的研究[J]药学学报,1980(04).
  • 9不稳定性心绞痛诊断和治疗建议[J].中华心血管病杂志,2000,28(6):409-412. 被引量:2695
  • 10任显峰,白慧丽,郑素娟.冠心病患者的情绪障碍和述情障碍[J].健康心理学杂志,2003,11(3):231-232. 被引量:16

共引文献2883

同被引文献62

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部